Health News

First HIV immunotherapy drug proves safe in phase 1 trial

First ever HIV immunotherapy drug proves safe in phase 1 trial – paving the way to a cure Scientists at UNC and Children’s National Health System have proved the safety of immunotherapy in HIV patients They are receiving $4m a year for 5 years from GlaxoSmithKline in a bid to arrive at the first HIV cure […]